publication venue for
- Defining the role of the immune system in cancer treatment: highlights from the Immunochemotherapy Conference. 2011
- What is the role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?. 23. 2023
- Avelumab: is it time to get excited?. 18. 2018
- Tumor microenvironment regulates epithelial-mesenchymal transitions in metastasis.. 12. 2012
- Targeting thrombosis in exocrine pancreas cancer: a continued need for improved therapies.. 11. 2011
- Margins in breast-conserving therapy: have we lost sight of the big picture?. 8. 2008
- Adjuvant aromatase inhibitors and emerging quality-of-life considerations.. 8. 2008
- Risk stratification of upper tract urothelial carcinoma: A Review of the Current Literature. 2019
- The role of tivozanib in advanced renal cell carcinoma therapy. 2018
- Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer. 2018
- New surgical approaches for clinically high-risk or metastatic prostate cancer. 2017
- Liver-directed therapy in metastatic colorectal cancer. 2017
- New advances in focal therapy for early stage prostate cancer. 2017
- The role of adjuvant therapy in uterine leiomyosarcoma. 2015
- Health technology assessment in evolution - focal therapy in localised prostate cancer. 2014
- Emerging role of stereotactic body radiotherapy in the treatment of pancreatic cancer. 2013
- Stereotactic body radiation therapy for metastasis to the adrenal glands. 2012
- Clinical trial end points for assessing efficacy of novel therapies for soft-tissue sarcomas. 2012
- Improving end-of-life care for head and neck cancer patients. 2012
- Emerging applications of stereotactic body radiation therapy for head and neck cancer. 2011
- The important role of radiation therapy in early-stage diffuse large B-cell lymphoma: time to review the evidence once again. 2011
- Emerging application of stereotactic body radiation therapy for gynecologic malignancies. 2011
- Imaging changes after stereotactic body radiation therapy for lung and liver tumors. 2011
- HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies. 2011
- Management of upper urinary tract urothelial carcinoma. 2010
- Novel strategies for treating relapsed/refractory urothelial carcinoma. 2010
- Glioma stem cell signaling: therapeutic opportunities and challenges. 2010
- Lymph node dissection for bladder cancer: the issue of extent and feasibility in the minimally invasive era. 2009
- Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma. 2009
- Stereotactic body radiation therapy for oligometastases. 2009
- Novel anti-tubulin cytotoxic agents for breast cancer. 2009
- Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction. 2008
- Stereotactic body radiation therapy for nonpulmonary primary tumors. 2008
- Epothilones in breast cancer: current status and future directions. 2008
- Predicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis. 2008
- Tribulations or triumphs in prostate cancer immunotherapy: on the road to victory? 2008
- Emerging therapies for malignant glioma. 2007
- Targeted therapies for soft-tissue sarcomas. 2007
- Treatment of acute myeloid leukemia in older patients. 2007
- Partial nephrectomy achieves local tumor control and prevents chronic kidney disease. 2006
- Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions. 2006
- Update on surgical treatment for endometrial cancer. 2005
- Optimal therapy and management of endometrial cancer. 2003
- Gene therapy for prostate cancer. 2002
- Clinical efficacy and safety of bispecific antibodies for the treatment of solid tumors: a systematic review and meta-analysis. 2023
- Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology. 2019
- Anti-GD2 immunotherapy for neuroblastoma. 2017
- External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma. 2016
- Extra-CNS metastasis from glioblastoma: a rare clinical entity. 2015
- Stereotactic body radiation therapy in pancreatic cancer: the new frontier. 2014
- Locally ablative therapies for primary and metastatic liver cancer. 2014
- Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update. 2011
- High-dose chemotherapy and stem cell transplantation for advanced testicular cancer. 2011
- Is there a role for presurgical therapy for renal cell carcinoma? 2010
- Circulating tumor cells as prognostic marker in metastatic breast cancer. 2010
- Novel therapeutics for melanoma. 2009
- Prostatic transitional cell carcinoma: pathologic features and clinical management. 2007
- Mathematical modeling of cancer progression and response to chemotherapy. 2006
- Chemotherapy resistance in osteosarcoma: current challenges and future directions. 2006
- Adjuvant chemotherapy for bladder cancer. 2005
- Promises and pitfalls in the prediction of antiepidermal growth factor receptor activity. 2005